We believe software can treat disease by changing the behaviors that cause it. Pioneering prescription digital therapeutics to treat cardiometabolic conditions.
San Francisco, CA
Joined March 2016
- Tweets793
- Following512
- Followers1.1K
- Likes411
Better Therapeutics retweeted
Why do many patients with #T2D struggle with making lifestyle changes that stick? Join @Better_Tx to learn more about the science behind cognitive behavioral therapy and see how AspyreRx can help your patients succeed.
Learn more 👉 bit.ly/3wwQAoR
#breakingnews An innovative partnership with ACLM is set to expand access to AspyreRx to patients in underserved communities disproportionately affected by #T2D
businesswire.com/news/home/2…
#news FDA grants Breakthrough Device Designation for our novel CBT platform targeting patients with advanced liver disease. Read more 👉
businesswire.com/news/home/2…
#news In a step towards securing broad coverage for AspyreRx, we announced today a rebate agreement with a large PBM in the US.
businesswire.com/news/home/2…
The versatility of our therapeutic approach across a broad spectrum of cardiometabolic conditions is an exciting and unique aspect of our platform. Furthermore, the digital nature of our products allows for potential expansion in a fraction of the time... businesswire.com/news/home/2…
Are you a #diabetes educator? Interesting in learning how to help your patients make and sustain behavior change? Join @ADCESdiabetes for a product overview webinar to discover how AspyreRx can help. Register now at bit.ly/410B9A8.
🗓️ Join us on Thursday at 1pm EST to discover how behavior change can be powerful medicine. Register here adces.org/events/virtual/det…
Discover a new way to treat type 2 diabetes – and it’s not a drug. Join us for our upcoming webinar to learn how AspyreRx™ can help your patients make and maintain positive behavior changes to improve their type 2 diabetes. Register at bit.ly/410B9A8.
Better Therapeutics retweeted
Discover a new way to treat type 2 diabetes – and it’s not a drug. Join us for our upcoming webinar to learn how AspyreRx™ can help your patients make and maintain positive behavior changes to improve their type 2 diabetes. Register at bit.ly/410B9A8.
Despite advances in #pharmacotherapy, there remains a pressing need to revolutionize the approach to #diabetes treatment. We are utilizing #tech on our mission to advance human health through the power of behavior change. benzinga.com/general/biotech…
On #WorldDiabetesDay we are thrilled to share we have been awarded the 🏆 2023 Technology Innovation Leadership Award for #AspyreRx, a digital behavioral treatment for people living with #type2diabetes. Read the full @Frost_Sullivan report 👉 lnkd.in/dNBb-U25
Wrapping up at #LM2023! It's been inspiring connecting with the #lifestylemedicine community, sharing insights, and exploring innovative approaches. The support & feedback for #AspyreRx has been incredible. Together, we believe behavior change can be powerful medicine.
#AspyreRx is on showcase at #LM2023! The team are thrilled to be here in Denver with the #lifestylemedicine community to drive the transformation of #healthcare. Visit us at the booth to learn more. @ACLifeMed
#news We are days away from the @ACLifeMed's #LM2023 meeting in Denver. #AspyreRx will be on showcase and we are excited to share it with the #lifestylemedicine and #healthcare community. Read more 👉 lnkd.in/gRr6EV_Q
Behavior change can be powerful #medicine. Today, adults with T2D have a new treatment option that requires a prescription - and it’s not a drug. AspyreRx is now live in app stores and healthcare providers across the U.S. can start prescribing today. aspyrerx.com
Better Therapeutics Announces Launch of AspyreRx to Treat Adults with Type 2 Diabetes - businesswire.com/news/home/2…
Better Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 Diabetes - businesswire.com/news/home/2…
As we witness the transformative impact of digital therapeutics on conditions like type 2 diabetes, MASLD and MASH, we envision a future where PDTs not only serve as first-line treatments, but also complement pharmacotherapy, empowering patients to... businesswire.com/news/home/2…
Better Therapeutics Completes Enrollment in Real-World Evidence Program Evaluating Long-term Effectiveness of AspyreRx in Type 2 Diabetes - businesswire.com/news/home/2…
Diabetes Prevalence Continues To Rise – Better Therapeutics' Digital Treatment Could Help Change This Trajectory $BTTX $LLY $NVO benzinga.com/general/biotech… via @Benzinga
Are you attending #DTxEast2023 in #Boston next month? Join our CEO Frank Karbe and Chief Commercial Officer Diane Gomez-Thinnes there for the #DTx industry's premier event.
